Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 34 results.
User Information
Export Records
  1. 2.   Discovery and Optimization of 2H-1 lambda(2)-Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of Cancer
  2. Rohde, Jason M.; Karavadhi, Surendra; Pragani, Rajan; Liu, Li; Fang, Yuhong; Zhang, Weihe; McIver, Andrew; Zheng, Hongchao; Liu, Qingyang; Davis, Mindy; Urban, Daniel J.; Lee, Tobie D.; Cheff, Dorian M.; Hollingshead,Melinda; Henderson, Mark J.; Martinez, Natalia J.; Brimacombe, Kyle R.; Yasgar, Adam; Zhao, Wei; Klumpp-Thomas, Carleen; Michael, Sam; Covey, Joseph; Moore,Bill; Stott, Gordon M.; Li, Zhuyin; Simeonov, Anton; Jadhav, Ajit; Frye, Stephen; Hall, Matthew D.; Shen, Min; Wang, Xiaodong; Patnaik, Samarjit; Boxer, Matthew B.
  3. Journal of Medicinal Chemistry. 2021, Apr 22; 64(8): 4913-4946.
  1. 3.   CENP-A overexpression promotes aneuploidy with karyotypic heterogeneity
  2. Shrestha, Roshan L.; Rossi, Austin; Wangsa, Darawalee; Hogan, Ann K.; Zaldana, Kimberly S.; Suva, Evelyn; Chung, Yang Jo; Sanders,Chelsea; Difilippantonio,Simone; Karpova, Tatiana S.; Karim,Baktiar; Foltz, Daniel R.; Fachinetti, Daniele; Aplan, Peter D.; Ried, Thomas; Basrai, Munira A.
  3. The Journal of Cell Biology. 2021, Feb 23; 220(4):
  1. 4.   Genomic mapping in outbred mice reveals overlap in genetic susceptibility for HZE ion- and gamma-ray-induced tumors
  2. Edmondson,Elijah; Gatti, D. M.; Ray, F. A.; Garcia, E. L.; Fallgren, C. M.; Kamstock, D. A.; Weil, M. M.
  3. SCIENCE ADVANCES. 2020, Apr; 6(16): eaax5940.
  1. 5.   Antibody-drug conjugates for cancer
  2. Chau, Cindy H.; Steeg,Pat; Figg, William D.
  3. Lancet (London, England). 2019, Aug 31; 394(10200): 793-804.
  1. 6.   GATA2 Deficiency: Early Identification for Improved Clinical Outcomes
  2. Cole, Kristen; Avila, Daniele; Parta,Mark; Schuver, Bazetta; Holland, Steven; Shah, Nirali; Hickstein, Dennis
  3. Clinical journal of oncology nursing. 2019, Aug 01; 23(4): 417-422.
  1. 7.   Heterogeneity in refractory acute myeloid leukemia
  2. Horibata, Sachi; Gui, Gege; Lack,Justin; DeStefano, Christin B; Gottesman, Michael M; Hourigan, Christopher S
  3. Proceedings of the National Academy of Sciences of the United States of America. 2019, MAY 21; 116(21): 10494-10503.
  1. 8.   IL-15/IL-15R alpha/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice
  2. Shi, Yimin; Dincheva-Vogel, Lillie; Ayemoba, Charles E.; Fung, Jeffrey P.; Bergamaschi, Cristina; Pavlakis, George; Farzaneh, Farzin; Gaensler, Karin M. L.
  3. BLOOD ADVANCES. 2018, NOV 27; 2(22): 3177-3192.
  1. 9.   Pharmacologic inhibition of dihydroorotate dehydrogenase induces apoptosis and differentiation in acute myeloid leukemia cells
  2. Wu, Dang; Wang, Wanyan; Chen, Wuyan; Lian, Fulin; Lang, Li; Huang, Ying; Xu, Yechun; Zhang, Naixia; Chen, Yinbin; Liu, Mingyao; Nussinov, Ruth; Cheng, Feixiong; Lu, Weiqiang; Huang, Jin
  3. Haematologica. 2018, Aug 31; 103(9): 1472-1483.
  1. 10.   Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia
  2. Kim, Miriam Y; Yu, Kyung-Rok; Kenderian, Saad S; Ruella, Marco; Chen, Shirley; Shin, Tae-Hoon; Aljanahi, Aisha A; Schreeder, Daniel; Klichinsky, Michael; Shestova, Olga; Kozlowski, Miroslaw S; Cummins, Katherine D; Shan, Xinhe; Shestov, Maksim; Bagg, Adam; Morrissette, Jennifer J D; Sekhri, Palak; Lazzarotto, Cicera R; Calvo, Katherine R; Kuhns, Doug; Donahue, Robert E; Behbehani, Gregory K; Tsai, Shengdar Q; Dunbar, Cynthia E; Gill, Saar
  3. Cell. 2018, May 31; 173(6): 1439-1453.e19.
  1. 11.   PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
  2. Gryder, Berkley E.; Yohe, Marielle E.; Chou, Hsien-Chao; Zhang, Xiaohu; Marques, Joana; Wachtel, Marco; Schaefer, Beat; Sen, Nirmalya; Song, Young; Gualtieri, Alberto; Pomella, Silvia; Rota, Rossella; Cleveland, Abigail; Wen, Xinyu; Sindiri, Sivasish; Wei, Jun S.; Barr, Frederic G.; Das, Sudipto; Andresson, Thorkell; Guha, Rajarshi; Lal-Nag, Madhu; Ferrer, Marc; Shern, Jack F.; Zhao, Keji; Thomas, Craig J.; Khan, Javed
  3. Cancer Discovery. 2017, Aug; 7(8): 884-899.
  1. 12.   Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated Fusarium solani infection.
  2. Sheela, Sheenu; Ito, Sawa; Strich, Jeffrey R; Manion, Maura; Montemayor-Garcia, Celina; Wang, Hao-Wei; Oetjen, Karolyn A; West, Kamile A; Barrett, Austin J; Parta, Mark; Gea-Banacloche, Juan; Holland, Steven M; Hourigan, Christopher S; Lai, Catherine
  3. Leukemia research reports. 2017, Jul 18; 8: 4-6.
  1. 13.   Hematopoiesis and leukemogenesis in mice expressing oncogenic Nras(G12D) from the endogenous locus
  2. Li, Q.; Haigis, K. M.; McDaniel, A.; Harding-Theobald, E.; Kogan, S. C.; Akagi, K.; Wong, J. C. Y.; Braun, B. S.; Wolff, L.; Jacks, T.; Shannon, K.
  3. Blood. 2011, Feb; 117(6): 2022-2032.
  1. 14.   Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation
  2. Yap, D. B.; Chu, J.; Berg, T.; Schapira, M.; Cheng, S. W. G.; Moradian, A.; Morin, R. D.; Mungall, A. J.; Meissner, B.; Boyle, M.; Marquez, V. E.; Marra, M. A.; Gascoyne, R. D.; Humphries, R. K.; Arrowsmith, C. H.; Morin, G. B.; Aparicio, S.
  3. Blood. 2011, Feb; 117(8): 2451-2459.
  1. 15.   Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
  2. Shurin, M. R.; Gregory, M.; Morris, J. C.; Malyguine, A. M.
  3. Expert Opinion on Biological Therapy. 2010, Nov; 10(11): 1539-1553.
  1. 16.   Identification of Vitronectin as an Extrinsic Inducer of Cancer Stem Cell Differentiation and Tumor Formation
  2. Hurt, E. M.; Chan, K.; Serrat, M. A. D.; Thomas, S. B.; Veenstra, T. D.; Farrar, W. L.
  3. Stem Cells. 2010, Mar 31; 28(3): 390-398.
  1. 17.   Recent Development of Cyclic Amide (Pyridone/Lactam) Moiety Containing Heterocycles as Protein Kinase Inhibitors
  2. Wei, L. Y.; Malhotra, S. V.
  3. Current Medicinal Chemistry. 2010, Jan; 17(3): 234-253.
  1. 18.   JS-K, an arylating nitric oxide (NO) donor, has synergistic anti-leukemic activity with cytarabine (ARA-C)
  2. Shami, P. J.; Maciag, A. E.; Eddington, J. K.; Udupi, V.; Kosak, K. M.; Saavedra, J. E.; Keefer, L. K.
  3. Leukemia Research. 2009 33(11): 1525-1529.
  1. 19.   Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR
  2. Yao, X. H.; Ping, Y. F.; Chen, J. H.; Xu, C. P.; Chen, D. L.; Zhang, R.; Wang, J. M.; Bian, X. W.
  3. Journal of Pathology. 2008 215(4): 369-376.
  1. 20.   Isolation and characterization of stem cell-like precursor cells from primary human anaplastic oligoastrocytoma
  2. Yi, L.; Zhou, Z. H.; Ping, Y. F.; Chen, J. H.; Yao, X. H.; Feng, H.; Lu, J. Y.; Wang, J. M.; Bian, X. W.
  3. Modern Pathology. 2007, Oct; 20(10): 1061-1068.
  1. 21.   Genetic ablation of CCAAT/Enhancer binding protein alpha in epidermis reveals its role in suppression of epithelial tumorigenesis
  2. Loomis, K. D.; Zhu, S.; Yoon, K.; Johnson, P. F.; Smart, R. C.
  3. Cancer Research. 2007, Jul; 67(14): 6768-6776.
  1. 22.   Cancer stem cells - Redefining the paradigm of cancer treatment strategies
  2. Dean, M.
  3. Molecular Interventions. 2006, Jun; 6(3): 140-148.
  1. 23.   Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis
  2. Du, Y.; Spence, S. E.; Jenkins, N. A.; Copeland, N. G.
  3. Blood. 2005, OCT 1; 106(7): 2498-2505.
  1. 24.   Tumour stem cells and drug resistance
  2. Dean, M.; Fojo, T.; Bates, S.
  3. Nature Reviews Cancer. 2005 5(4): 275-284.
  1. 25.   Role of protein-protein interactions in the antiapoptotic function of EWS-Fli-1
  2. Ramakrishnan, R.; Fujimura, Y.; Zou, J. P.; Liu, F.; Lee, L.; Rao, V. N.; Reddy, E. S. P.
  3. Oncogene. 2004, SEP 16; 23(42): 7087-7094.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel